Industry Update: Medical Devices

Industry Highlights

  • On June 15, 2022 Boston Scientific Corporation (NYSE: BSX) announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake (approximately 64 percent) of M.I.Tech Co., Ltd, (“M.I.Tech”) a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures. M.I.Tech is the creator of the HANAROSTENT™ technology, a family of conformable, non-vascular, self-expanding metal stents, which have been distributed by Boston Scientific in Japan since 2015.
  • On May 13, 2022 Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it has completed the acquisition of Intersect ENT, expanding the company’s comprehensive ear, nose, and throat (ENT) portfolio with innovative products used in sinus procedures to improve post-operative outcomes and to treat nasal polyps.

Past Industry Updates

Medical Devices: April 2022

Medical Devices: February 2022

Medical Devices: October 2021

Medical Devices: July 2021

Medical Devices: May 2021

Medical Devices: January 2021

Medical Devices: October 2020

Medical Devices: July 2020

Medical Devices: May 2020

Medical Devices: December 2019

Medical Devices: October 2019

More Industry Reports

Related Posts

Senior VRC Executive William Hughes to Retire

Senior Managing Director William Hughes is retiring at the end of the year. Over a nearly two-and-a-half decades-long career at VRC, Hughes served as co-CEO from 2001-2017, a period that delivered rapid growth for the firm.

VRC’s Tom Gottfried to Present Transfer Pricing and Tax Valuation for Restructurings

Tax, transfer pricing, and finance executives will benefit from understanding the relevant transfer pricing and tax valuation standards and requirements associated with business restructurings and reorganizations.

Evaluating Private Company Lease Accounting Options Under ASC 842

The holiday is nearly over for many private companies with significant right-of-use assets meaning companies will need to adopt ASC 842 effective Jan. 1, 2023, in preparation for their first calendar year-end reporting date.